A strategy for the use of cardiac injury markers (troponin I and T, creatine kinase-MB mass and isoforms, and myoglobin) in the diagnosis of acute myocardial infarction

Archives of Pathology and Laboratory Medicine

Volumn 122, Issue 3, 1998, Pages 245-251

  Kost, Gerald J ^a   Kirk, J Douglas ^b   Omand, Kathy ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CREATINE KINASE MB; MYOGLOBIN; TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; COST; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; EMERGENCY WARD; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; PREDICTION; RISK ASSESSMENT; THORAX PAIN;

BIOLOGICAL MARKERS; CREATINE KINASE; HUMANS; ISOENZYMES; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOGLOBIN; TIME FACTORS; TROPONIN I; TROPONIN T;

EID: 0031943823     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Bodor GS, Porter S, Landt Y, Ladenson JH. Development of monoclonal antibodies for an assay of cardiac troponin-l and preliminary results in suspected cases of myocardial infarction. Clin Chem. 1992;38:2203-2214.
2. Adams JE, Bodor GS, Davila-Roman VG, et al. Cardiac troponin I: a marker with high specificity for cardiac injury. Circulation. 1993;88:101-106.
3. Apple FS. Measurement of cardiac troponin-I in serum for the detection of myocardial infarction. J Int Fed Clin Chem. 1996;8:148-150.
4. Mair J, Genser N, Morandell D, et al. Cardiac troponin I in the diagnosis of myocardial injury and infarction. Clin Chim Acta. 1996;245:19-38.
5. Zaninotto M, Altinier S, Lachin M, Carraro P, Plebani M. Fluoroenzymometric method to measure cardiac troponin I in sera of patients with myocardial infarction. Clin Chem. 1996;42:1460-1466.
6. Katus HA, Remppis A, Diederich KW, Scheffold T, Kubler W. Serum concentration changes of cardiac troponin T in patients with acute myocardial infarction. J Mol Cell Cardiol. 1989;21:1349-1353.
7. Katus HA, Remppis A, Neumann FJ, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 1991;83:902-912.
8. Mair J, Artner-Dworzak D, Lechleitner P, et al. Cardiac troponin T in diagnosis of acute myocardial infarction. Clin Chem. 1991;37:845-852.
9. Mair J, Dienstl F, Puschendorf B. Cardiac troponin T in the diagnosis of myocardial injury. Crit Rev Clin Lab Sci. 1992;29:31-57.
10. Puelo PR, Guadagno PA, Roberts R, Perryman MB. Sensitive, rapid assay of subforms of creatine kinase MB in plasma. Clin Chem. 1989;357:1452-1455.
11. Puelo PR, Guadagno PA, Roberts R, et al. Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB. Circulation. 1990;82:759-764.
12. Puelo PR, Meyer D, Wathen C, et al. Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction. N Engl J Med. 1994;331:561-566.
13. Stone MJ, Waterman MR, Harimoto D, et al. Serum myoglobin level as a diagnostic test in patients with acute myocardial infarction. Br Heart J. 1977;39: 375-380.
14. Gibler WB, Gibler CD, Weinshenker E, et al. Myoglobin as an early indicator of acute myocardial infarction. Ann Emerg Med. 1987;16:851-856.
15. Brogan GX, Friedman S, McCuskey C, et al. Evaluation of a new rapid quantitative immunoassay for serum myoglobin versus CK-MB for ruling out acute myocardial infarction in the emergency department. Ann Emerg Med. 1994;24: 665-671.
16. Tucker JF, Collins RA, Anderson AJ, et al. Value of serial myoglobin levels in the early diagnosis of patients admitted for acute myocardial infarction. Ann Emerg Med. 1994;24:704-708.
17. Montague C, Kircher T. Myoglobin in the early evaluation of acute chest pain. Am J Clin Pathol. 1995;104:472-476.
18. Woo J, Lacbawan FL, Sunheimer R, LeFever D, McCabe JB. Is myoglobin useful in the diagnosis of acute myocardial infarction in the emergency department setting? Am I Clin Pathol. 1995;103:725-729.
19. Apple FS, Lowe M. Cardiac troponin subunits I and T versus creatine kinase-MB in the diagnosis of myocardial injury and acute myocardial infarction. In: Check Sample. Chicago, III: American Society of Clinical Pathologists, Clinical Chemistry no. CC-95-7 (CC-265), 1995:35:99-116.
20. Keffer JH. Myocardial markers of injury: evolution and insights. Am J Clin Pathol. 1996;105:305-320.
21. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342-1349.
22. Ohman EM, Armstrong PW, Christenson RH, et al. Cardiac troponin T levels for risk stratification in acute myocardial infarction. N Engl J Med. 1996; 335:1333-1341.
23. Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 1992;327:146-150.
24. Wu AHB, Abbas SA, Green S, et al. Prognostic value of cardiac troponin T in unstable angina. Am J Cardiol. 1995;76:970-972.
25. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation. 1996;93:1651-1657.
26. Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. Br Med J. 1996;313:262-264.
27. Guest TM, Ramanathan AV, Tuteur PG, Schechtman KB, Ladenson JH, Jaffe AS. Myocardial injury in critically ill patients: a frequently unrecognized complication. JAMA. 1995;273:1945-1949.
28. Bernard R, Corday E, Eliasch H, et al. Nomenclature and criteria for diagnosis of ischemic heart disease: report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Circulation. 1979;59:607-609.
29. Shott S. Statistics for Health Professionals. Philadelphia, Pa: WB Saunders Co; 1990:70-72, 245-248.
30. Zar JH. Biostatistical Analysis. Englewood Cliffs, NJ: Prentice-Hall; 1984: 228-230.
31. Apple FS, Wu AH, Valdes R. Serum cardiac troponin T concentrations in hospitalized patients without acute myocardial infarction. Scand J Clin Lab Invest. 1996;56:63-68.
32. Baum H, Obst M, Huber U, Neumeier D. Cardiac troponin T in patients with high creatinine concentration but normal creatine kinase activity in serum. Clin Chem. 1996;42:474-475.
33. Fitzgerald RL, Frankel WL, Herold DA. Comparison of troponin-T with other cardiac markers in a VA hospital. Am J Clin Pathol. 1996;106:396-401.
34. Hafner G, Thome-Kromer B, Schaube J, et al. Cardiac troponins in serum in chronic renal failure. Clin Chem. 1994;40:1790-1791.
35. Bhayana V, Gougoulias T, Cohoe S, Henderson AR. Discordance between resuits for troponin T and troponin I in renal disease. Clin Chem. 1995;41:312-317.
36. Frankel WL, Herold DA, Ziegler TW, Fitzgerald RL. Cardiac troponin T is elevated in asymptomatic patients with chronic renal failure. Am J Clin Pathol. 1996;106:118-123.
37. Wu AHB, Feng YJ, Roper L, Herbert K, Schweizer R. Cardiac troponins T and I before and after renal transplantation. Clin Chem. 1997;43:411-412.
38. Collinson PO. To T or not to T, that is the question. Clin Chem. 1997;43: 421-423.
39. Lofberg M, Tahtela R, Harkonen M, Somer H. Cardiac troponins in severe rhabdomyolysis. Clin Chem. 1996;42:1120-1121.
40. Sasse S, Brand N, Kyprianou P, et al. Troponin I gene expression during human cardiac development and in end-stage heart failure. Circ Res. 1993;72: 932-938.
41. Bodor GS, Proterfield D, Voss EM, Smith S, Apple FS. Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem. 1995;41:1710-1715.
42. Apple FS, Henry TD, Berger CR, Landt YA. Early monitoring of serum cardiac troponin I for assessment of coronary reperfusion following thrombolytic therapy. Am J Clin Pathol. 1996;105:6-10.
43. Trinquier S, Flecheux O, Bullenger M, Castex F. Highly specific immunoassay for cardiac troponin I assessed in noninfarct patients with chronic renal failure or severe polytrauma. Clin Chem. 1995;41:1675-1676.
44. Wu AHB, Feng YJ, Contois JH, Pervaiz S. Comparison of myoglobin, creatine kinase-MB, and cardiac troponin for diagnosis of acute myocardial infarction. Ann Clin Lab Sci. 1996;26:291-300.
45. Mair J, Morandell D, Genser N, Lechleitner P, Dienstl F, Puschendorf B. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. Clin Chem. 1995;41:1266-1272.
46. Laurino JP, Fischberg-Bender E, Galligan S, Chang J. An immunochemical mass assay for the direct measurement of creatine kinase MB2. Ann Clin Lab Sci. 1995;25:252-263.
47. Laurino JP, Bender EW, Kessimian N, Chang J, Pelletier T, Usategui M. Comparative sensitivities and specificities of the mass measurements of CK-MB2, CK-MB, and myoglobin for diagnosing acute myocardial infarction. Clin Chem. 1996;42:1454-1459.
48. Tucker JF, Collins RA, Anderson AJ, Hauser J, Kalas J, Apple FS. Early diagnostic efficiency of cardiac troponin I and troponin T for acute myocardial infarction. Acad Emerg Med. 1997;4:13-21.
49. Jaffe AS, Landt Y, Parvin CA, Abendschein DR, Geltman EM, Ladenson JH. Comparative sensitivity of cardiac troponin I and lactate dehydrogenase isoenzymes for diagnosing acute myocardial infarction. Clin Chem. 1996;42:1770-1776.
50. Martins JT, Li DJ, Baskin LB, Jialal I, Keffer JH. Comparison of cardiac troponin I and lactate dehydrogenase isoenzymes for the late diagnosis of myocardial injury. Am I Clin Pathol. 1996;106:705-708.
51. Lewis WR, Amsterdam EA. Utility and safety of immediate exercise testing of low-risk patients admitted to the hospital for suspected acute myocardial infarction. Am J Cardiol. 1994;74:987-990.
52. Gibler WB, Runyon JP, Levy RC, et al. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Ann Emerg Med. 1995;25:1-8.
53. Hedges JR, Gibler WB, Young GP, et al. Multicenter study of creatine kinase-MB use: effect on chest pain clinical decision making. Acad Emerg Med. 1996;3:7-15.
54. Kontos MC, Anderson FP, Hanbury CM, Roberts CS, Miller WG, Jesse RL. Use of the combination of myoglobin and CK-MB mass for the rapid diagnosis of acute myocardial infarction. Am J Emerg Med. 1997;15:14-19.
55. Mair J, Smidt J, Lechleitner P, Dienstl F, Puschendorf B. Rapid accurate diagnosis of acute myocardial infarction in patients with nontraumatic chest pain within 1 h of admission. Coronary Art Dis. 1995;6:539-545.
56. Mair J, Smidt J, Lechleitner P, Dienstl F, Puschendorf B. A decision tree for the early diagnosis of acute myocardial infarction in nontraumatic chest pain patients at hospital admission. Chest. 1995;108:1502-1509.
57. Bernstein L, Spiekerman AM, Qamar A, Babb J. Effective resource management using a clinical and laboratory algorithm for chest pain triage. Clin Lab Management Rev. 1996;10:143-152.
58. Gomez MA, Anderson JL, Karagounis LA, Muhlestein JB, Mooers FB. An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO). J Am Coll Cardiol. 1996;28:25-33.
59. Wong SS. Strategic utilization of cardiac markers for the diagnosis of acute myocardial infarction. Ann Clin Lab Sci. 1996;26:301-312.
60. Tatum JL, Jesse RL, Kontos MC, et al. Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med. 1997;29:116-125.
61. Apple FS, Falahati A, Paulsen PR, Miller EA, Sharkey SW. Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I. Clin Chem. 1997;43:2047-2051.
62. Brogan GX, Hollander JE, McCuskey CF, et al. Evaluation of a new assay for cardiac troponin I vs creatine kinase-MB for the diagnosis of acute myocardial infarction. Acad Emerg Med. 1997;4:6-12.
63. Pervaiz S, Anderson FP, Lohmann TP, et al. Comparative analysis of cardiac troponin 1 and creatine kinase-MB as markers of acute myocardial infarction. Clin Cardiol. 1997;20:269-271.
64. Muller-Bardorff M, Hallermayer K, Schroder A, et al. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem. 1997;43:458-466.
65. Baum H, Braun S, Gerhardt W, et al. Multicenter evaluation of a second- generation assay for cardiac troponin T. Clin Chem. 1997;43:1877-1884.
66. Wu AHB, Clive JM. Impact of CK-MB testing policies on hospital length of stay and laboratory costs for patients with myocardial infarction or chest pain. Clin Chem. 1997;43:326-332.
67. Collinson PO, Ramhamadamy EM, Stubbs PJ, et al. Rapid enzyme diagnosis of patients with acute chest pain reduces patient stay in the coronary care unit. Ann Clin Biochem. 1993;30:17-22.
68. Apple FS, Preese LM, Riley L, Gerken KL, Van Lente F. Financial impact of a rapid CK-MB-specific immunoassay on the diagnosis of myocardial infarction. Arch Pathol Lab Med. 1990;114:1017-1020.
69. Christenson RH, Fitzgerald RL, Ochs L, et al. Characteristics of a 20-minute whole blood rapid assay for cardiac troponin T. Clin Biochem. 1997;30:27-33.
70. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T and troponin I. N Engl J Med. 1997;337:1648-1653.
71. Wu AHB, Feng YJ, Contois IH, Azar R, Waters D. Prognostic value of cardiac troponin I in patients with chest pain. Clin Chem. 1996;42:651-652.
72. Kollef MH, Ladenson JH, Eisenberg PR. Clinically recognized cardiac dysfunction: an independent determinant of mortality among critically ill patients. Is there a role for serial measurement of cardiac troponin I? Chest. 1997;111:1340-1347.
73. Anderson FP, Jesse RL, Nicholson CS, Miller WG. The costs and effectiveness of a rapid diagnostic and treatment protocol for myocardial infarction. In: Bowie LJ, Mannheim L, Silverstein MD, et al, eds. Assessing Clinical Outcomes: Utilizing Appropriate Laboratory Testing to Decrease Healthcare Costs and Improve Patient Outcomes. Washington, DC: American Association for Clinical Chemistry Press; 1996:20-24.
74. Kost GJ. Point-of-Care Testing ⇒ The Hybrid Laboratory ⇒ Knowledge Optimization. In: Kost GJ, ed. Handbook of Clinical Automation, Robotics, and Optimization. New York, NY: lohn Wiley & Sons; 1996:757-838.
75. Keffer JH. The cardiac profile and proposed practice guideline for acute ischemic heart disease. Am J Clin Pathol. 1997;107:398-409.
76. Schreiber WE. Laboratory assessment of myocardial damage: which test is best? Am J Clin Pathol. 1997;107:383-384.
77. Mair J. Cardiac troponin I and T: are enzymes still relevant as cardiac markers? Clin Chim Acta. 1997;257:99-115.
78. Mair J. Progress in myocardial damage detection: new biochemical markers for clinicians. Crit Rev Clin Lab Sci. 1997;34:1-66.
79. D'Costa M, Fleming E, Patterson MC. Cardiac troponin I for the diagnosis of acute myocardial infarction in the emergency department. Am J Clin Pathol. 1997;108:550-555.